1. A Cancer-Selective Zinc Ionophore Inspired by the Natural Product Naamidine A
- Author
-
Rachel M. Vaden, Sasi Arunachalam, Celine B. Santiago, Ryan E. Looper, Justin M. Salvant, Katrin P. Guillen, Bryan E. Welm, Matthew S. Sigman, Satya S. Pathi, and Joseph B. Gibbons
- Subjects
0301 basic medicine ,Programmed cell death ,Ionophore ,01 natural sciences ,Biochemistry ,Article ,Mice ,03 medical and health sciences ,In vivo ,medicine ,Organoid ,Animals ,Humans ,Cell Proliferation ,Metal ion homeostasis ,Ionophores ,010405 organic chemistry ,Chemistry ,Clioquinol ,Imidazoles ,Cancer ,General Medicine ,medicine.disease ,0104 chemical sciences ,Cell biology ,Zinc ,030104 developmental biology ,Cancer cell ,Molecular Medicine ,Female ,medicine.drug - Abstract
We present data demonstrating the natural product mimic, zinaamidole A (ZNA), is a modulator of metal ion homeostasis causing cancer-selective cell death by specifically inducing cellular Zn(2+)-uptake in transformed cells. ZNA’s cancer selectivity was evaluated using metastatic, patient-derived breast cancer cells, established human breast cancer cell lines, and three-dimensional organoid models derived from normal and transformed mouse mammary glands. Structural analysis of ZNA demonstrated that the compound interacts with zinc through the N(2)-acyl-2-aminoimidazole core. Combination treatment with ZnSO(4) strongly potentiated ZNA’s cancer-specific cell death mechanism, an effect that was not observed with other transition metals. We show that Zn(2+)-dyshomeostasis induced by ZNA is unique and markedly more selective than other known Zn(2+)interacting compounds such as clioquinol. The in vivo bioactivity of ZNA was also assessed and revealed that tumor-bearing mice treated with ZNA had improved survival outcomes. Collectively, these data demonstrate that the N(2)-acyl-2aminoimidazole core of ZNA represents a powerful chemotype to induce cell death in cancer cells concurrently with a disruption in zinc homeostasis.
- Published
- 2018